At Kaleido, we are relentless in our drive to pursue rigorous science and pioneer new approaches that can transform lives. The microbiome remains a largely untapped frontier in healthcare, with a broad and growing body of research implicating it in a number of diseases and conditions. We are uniquely positioned to succeed in translating its promise into solutions for patients and caregivers. Our team is hard at work developing our Microbiome Metabolic Therapies (MMT™), which we believe have potential to be therapies across a variety of conditions. We invite you to learn more about our programs and clinical studies and how patients are at the heart of everything we do towards our mission of leading a revolution in human health.